Genomic predictors of radiation response: recent progress towards personalized radiotherapy for brain metastases
Abstract Radiotherapy remains a key treatment modality for both primary and metastatic brain tumors. Significant technological advances in precision radiotherapy, such as stereotactic radiosurgery and intensity-modulated radiotherapy, have contributed to improved clinical outcomes. Notably, however,...
Saved in:
| Main Authors: | Paul M. Harary, Sanjeeth Rajaram, Maggie S. Chen, Yusuke S. Hori, David J. Park, Steven D. Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-12-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-024-02270-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brain MRI and regional vulnerabilities to radiation necrosis: investigating the impact of stereotactic radiotherapy in brain metastases treatment
by: Carlo A. Mallio, et al.
Published: (2025-04-01) -
Survival impact of early MRI progression after stereotactic radiotherapy for brain metastases
by: Moncef Morjani, et al.
Published: (2025-03-01) -
Whole-Brain Radiotherapy Simultaneous Integrated Boost Intensity-Modulated Radiotherapy Combined With Anlotinib in the Treatment of Brain Metastases
by: Wei Tao MD, et al.
Published: (2025-02-01) -
Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
by: Stephanie E. Combs, et al.
Published: (2018-06-01) -
High incidence of radiation-induced brain necrosis in the periventricular deep white matter: stereotactic radiotherapy for brain metastases using volumetric modulated arc therapy
by: Takayuki Ohguri, et al.
Published: (2025-01-01)